SCHEMBL9944969

SCHEMBL9944969

CCCNC(=O)c1cc([N+](=O)[O-])c(NC)cc1N1CC2CC2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.37
HCAR3 P49019 2/20 0.36
NPC1 O15118 2/20 0.36
CYP3A4 P08684 1/20 0.36
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 6/20 0.35
KMT2A Q03164 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PKM P14618 1/20 0.34
CRHBP P24387 1/20 0.34
RAB9A P51151 1/20 0.34
CRHR2 Q13324 1/20 0.34
POLB P06746 1/20 0.34
PTGES O14684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944993 0.84 ALDH1A1 (0.40) ALDH1A1LMNAGAAMAPTKMT2A
SCHEMBL9944808 0.84 KMT2A (0.46) ALDH1A1GAAMAPTKMT2ASMN1; SMN2
SCHEMBL9945032 0.83 MAPT (0.48) ALDH1A1LMNAGAAMAPTKMT2A
SCHEMBL9944769 0.83 MAPT (0.48) ALDH1A1LMNAGAAMAPTKMT2A
SCHEMBL9944989 0.82 ALDH1A1 (0.44) ALDH1A1HCAR3NPC1LMNAGAA
SCHEMBL9944810 0.82 ALDH1A1 (0.42) ALDH1A1HCAR3NPC1MAPTKMT2A
SCHEMBL9945004 0.82 ALDH1A1 (0.42) ALDH1A1HCAR3NPC1MAPTKMT2A
SCHEMBL9944859 0.82 ALDH1A1 (0.48) ALDH1A1NPC1LMNAMAPTKMT2A
SCHEMBL9944953 0.79 ALDH1A1 (0.40) ALDH1A1NPC1LMNAMAPTKMT2A
SCHEMBL9946607 0.79 PTGES (0.43) ALDH1A1POLBPTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885HCAR3 228/4885NPC1 1695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.